Market Closed -
Other stock markets
|
After market 17:33:42 | |||
128.3 USD | -0.42% | 129.5 | +0.97% |
05:02pm | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.65% | 326B | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B | |
-3.34% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Eyes Expanded Blood Disorder Drug Pipeline Via $1.35 Billion Buyout of Imago BioSciences